X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (65629) 65629
Newsletter (2333) 2333
Newspaper Article (333) 333
Magazine Article (216) 216
Book Chapter (206) 206
Dissertation (100) 100
Transcript (38) 38
Publication (29) 29
Conference Proceeding (27) 27
Government Document (18) 18
Web Resource (16) 16
Book Review (13) 13
Book / eBook (10) 10
Reference (10) 10
Streaming Video (8) 8
Journal / eJournal (4) 4
Trade Publication Article (4) 4
Report (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43822) 43822
methotrexate (35976) 35976
female (26692) 26692
male (21265) 21265
middle aged (16254) 16254
adult (16223) 16223
methotrexate - therapeutic use (15833) 15833
methotrexate - administration & dosage (14004) 14004
aged (10994) 10994
oncology (9427) 9427
rheumatoid arthritis (8807) 8807
rheumatology (8520) 8520
treatment outcome (8411) 8411
animals (8164) 8164
antineoplastic combined chemotherapy protocols - therapeutic use (7735) 7735
methotrexate - adverse effects (7219) 7219
arthritis, rheumatoid - drug therapy (7160) 7160
chemotherapy (6714) 6714
adolescent (6481) 6481
child (6090) 6090
therapy (5841) 5841
drug therapy, combination (5757) 5757
antirheumatic agents - therapeutic use (5330) 5330
cancer (5236) 5236
methotrexate - pharmacology (5219) 5219
care and treatment (4650) 4650
research (4381) 4381
pharmacology & pharmacy (4278) 4278
arthritis (3859) 3859
cyclophosphamide - administration & dosage (3839) 3839
prognosis (3839) 3839
pregnancy (3764) 3764
retrospective studies (3621) 3621
child, preschool (3608) 3608
time factors (3601) 3601
mice (3475) 3475
rheumatoid-arthritis (3435) 3435
double-blind (3423) 3423
drug therapy (3406) 3406
hematology (3272) 3272
follow-up studies (3135) 3135
combined modality therapy (3090) 3090
immunosuppressive agents - therapeutic use (3049) 3049
rheumatoid factor (2975) 2975
infliximab (2903) 2903
doxorubicin - administration & dosage (2882) 2882
risk factors (2854) 2854
analysis (2814) 2814
medicine & public health (2767) 2767
fluorouracil - administration & dosage (2749) 2749
drug administration schedule (2739) 2739
dose-response relationship, drug (2738) 2738
disease (2627) 2627
breast neoplasms - drug therapy (2601) 2601
patients (2598) 2598
children (2552) 2552
efficacy (2525) 2525
vincristine - administration & dosage (2522) 2522
medicine, general & internal (2521) 2521
etanercept (2509) 2509
cyclophosphamide - therapeutic use (2501) 2501
antineoplastic combined chemotherapy protocols - adverse effects (2487) 2487
rats (2472) 2472
dermatology (2297) 2297
antirheumatic agents - adverse effects (2283) 2283
cisplatin - administration & dosage (2276) 2276
health aspects (2272) 2272
drugs (2256) 2256
remission induction (2241) 2241
cyclophosphamide (2182) 2182
psoriasis (2135) 2135
prospective studies (2134) 2134
aged, 80 and over (2127) 2127
immunology (2125) 2125
severity of illness index (2117) 2117
trial (2059) 2059
pediatrics (2033) 2033
antineoplastic agents - therapeutic use (2025) 2025
diagnosis (2008) 2008
obstetrics & gynecology (1980) 1980
toxicity (1955) 1955
dosage and administration (1943) 1943
surgery (1869) 1869
doxorubicin (1865) 1865
antineoplastic combined chemotherapy protocols - administration & dosage (1856) 1856
young adult (1848) 1848
cisplatin (1845) 1845
medical research (1826) 1826
tumor necrosis factor-alpha - antagonists & inhibitors (1824) 1824
antibodies, monoclonal - therapeutic use (1816) 1816
survival rate (1798) 1798
infant (1791) 1791
psoriasis - drug therapy (1743) 1743
biochemistry & molecular biology (1729) 1729
management (1727) 1727
methotrexate - metabolism (1713) 1713
antirheumatic agents - administration & dosage (1683) 1683
leukemia (1682) 1682
clinical trials as topic (1671) 1671
high-dose methotrexate (1627) 1627
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Gerstein Science - Theses (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
Stacks (1) 1
University Archives - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (61574) 61574
German (1987) 1987
Japanese (1551) 1551
French (1520) 1520
Spanish (632) 632
Russian (625) 625
Chinese (428) 428
Italian (397) 397
Polish (321) 321
Korean (187) 187
Portuguese (147) 147
Dutch (92) 92
Turkish (88) 88
Czech (72) 72
Danish (63) 63
Hungarian (62) 62
Hebrew (36) 36
Norwegian (34) 34
Swedish (30) 30
Bulgarian (23) 23
Croatian (22) 22
Serbian (20) 20
Finnish (17) 17
Slovak (17) 17
Persian (13) 13
Romanian (12) 12
Icelandic (4) 4
Slovenian (4) 4
Ukrainian (4) 4
Arabic (3) 3
Bosnian (2) 2
Greek (2) 2
Lithuanian (2) 2
Breton (1) 1
Estonian (1) 1
Indonesian (1) 1
Kurdish (1) 1
Latin (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Cochrane library, ISSN 1469-493X, 06/2016, Volume 2019, Issue 9, p. CD007102
Background This is the second update of a Cochrane review that was first published in 2009, Issue 1. Gestational trophoblastic neoplasia (GTN) is a rare but... 
Trophoblastic | Drug Administration Schedule | Antineoplastic Agents | Risk | Leucovorin | Dactinomycin | Gestational trophoblastic neoplasia | Randomized Controlled Trials as Topic | Gynaecology | Gynaecological | MISCELLANEOUS GYNAECOLOGICAL CANCER TOPICS | Gestational Trophoblastic Disease | Vitamin B Complex | Case‐Control Studies | Methotrexate | Medicine General & Introductory Medical Sciences | Cohort Studies | Cancer | Vitamin B Complex [administration & dosage] | Methotrexate [administration & dosage; adverse effects] | Humans | Antineoplastic Agents [administration & dosage; adverse effects] | FOLINIC ACID | Case-Control Studies | Leucovorin [administration & dosage] | MEDICINE, GENERAL & INTERNAL | CITROVORUM FACTOR RESCUE | PHASE-II TRIAL | Dactinomycin [administration & dosage; adverse effects] | WEEKLY INTRAMUSCULAR METHOTREXATE | Gestational Trophoblastic Disease [drug therapy] | Female | LOW-DOSE METHOTREXATE | SINGLE-AGENT METHOTREXATE | 5-DAY METHOTREXATE | Pregnancy | DISEASE | ORAL ETOPOSIDE | PULSE ACTINOMYCIN-D | Leucovorin - administration & dosage | Dactinomycin - administration & dosage | Antineoplastic Agents - administration & dosage | Vitamin B Complex - administration & dosage | Methotrexate - adverse effects | Antineoplastic Agents - adverse effects | Dactinomycin - adverse effects | Methotrexate - administration & dosage | Gestational Trophoblastic Disease - drug therapy
Journal Article
Journal Article
by Fleischmann, Roy and Mysler, Eduardo and Hall, Stephen and Kivitz, Alan J and Moots, Robert J and Luo, Zhen and DeMasi, Ryan and Soma, Koshika and Zhang, Richard and Takiya, Liza and Tatulych, Svitlana and Mojcik, Christopher and Krishnaswami, Sriram and Menon, Sujatha and Smolen, Josef S and Adams, Luthando and Ally, Mahmood M and du Plooy, Maria C and Louw, Ingrid C and Nayiager, Savithree and Nel, Christoffel B and Nel, Debra and Reuter, Helmuth and Soloman, Ahmed S and Spargo, Catherine E and Rischmueller, Maureen and Sharma, Shunil D and Will, Robert K and Youssef, Peter P and Arroyo, Caroline and Baes, Rosario P and Dulos, Roger B and Hao, Llewellyn T and Lanzon, Allan E and Lichauco, Juan Javier T and Mangubat, Jill H and Ramiterre, Edgar B and Reyes, Bernadette Heizel M and Tan, Perry P and Choe, Jung-Yoon and Kang, Young Mo and Kwon, Seong Ryul and Lee, Sang-Heon and Lee, Shin-Seok and Yoo, Dae-Hyun and Lin, Hsiao-Yi and Luo, Shue-Fen and Tsai, Shih-Tzu and Tsai, Wen-Chan and Tseng, Jui-Cheng and Wei, Cheng-Chung C and Asavatanabodee, Paijit and Nantiruj, Kanokrat and Nilganuwong, Surasak and Uea-Areewongsa, Parichat and Majstorovic, Ljubinka Bozic and Bacic, Suada Mulic and Batalov, Anastas Z and Georgieva-Slavcheva, Gabriela and Mihailova, Mariyana and Nikolov, Nikolay G and Penev, Dimitar P and Spasov, Yuliy A and Stanimirova, Krasimira and Todorov, Stoyan and Toncheva, Antoaneta R and Yordanova, Nadezhda and Mosterova, Zdenka and Novosad, Libor and Prochazkova, Leona and Stehlikova, Helena and Stejfova, Zuzana and Kiseleva, Natalia and Pank, Lea and Savi, Triin and Alexandra, Balbir-Gurman and Amital, Howard and Mevorach, Dror and Rosner, Itzhak A and Mihailova, Anna and Stumbra-Stumberga, Evija and Basijokiene, Vida and Lietuvininkiene, Virginija and Unikiene, Dalia and Brzezicki, Jan and Dudek, Anna M and Glowacka-Kulesz, Maria B and Grabowicz-Wasko, Barbara and Hajduk-Kubacka, Sabina and Hilt, Joanna and Hrycaj, Pawel and Jeka, Slawomir and Kolasa, Renata and Krogulec, Marek and Mastalerz, Hanna and Olak-Popko, Anna and Owczarek, Elzbieta and Ruzga, Zofia and Walczak, Alina and Ancuta, Codrina I and ... and ORAL Strategy investigators and ORAL Strategy Investigators
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article